Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Clerson

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pharmacology|June 9, 2023
Real-World Experience with a Human Fibrinogen Concentrate: Clinical Data from Adult and Pediatric Patients Requiring Fibrinogen for Bleeding Control and PreventionFrancois Stéphan, Loriane Gutermann, Stéphanie Bourget, et al.
Cardiology in the Young|March 17, 2016
Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE studyPascal Amedro, Adeline Basquin, Virginie Gressin, et al.
Joint Bone Spine|December 29, 2015
Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatmentThomas Bardin, Gérard Chalès, Tristan Pascart, et al.
Annals of the Rheumatic Diseases|November 27, 2012
Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management eraDavid Launay, Olivier Sitbon, Eric Hachulla, et al.
Arthritis Care & Research|August 4, 2015
Prevalence of Gout in the Adult Population of FranceThomas Bardin, Stéphane Bouée, Pierre Clerson, et al.
European Journal of Haematology|April 13, 2018
A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy-associated secondary immunodeficiencyOmar Benbrahim, Jean-François Viallard, Sylvain Choquet, et al.
Critical Care (London, England)|October 6, 2012
Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practiceThibaut Desmettre, Emilie Dehours, Charles-Marc Samama, et al.
Patient Preference and Adherence|July 27, 2017
A cohort of French pediatric patients with primary immunodeficiencies: are patient preferences regarding replacement immunotherapy fulfilled in real-life conditions?Marlène Pasquet, Isabelle Pellier, Nathalie Aladjidi, et al.
Chest|May 12, 2009
Is pulmonary arterial hypertension really a late complication of systemic sclerosis?Eric Hachulla, David Launay, Luc Mouthon, et al.
European Journal of Heart Failure|January 17, 2009
Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco ProgrammePascal de Groote, Richard Isnard, Pierre Clerson, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|June 9, 2023
Real-World Experience with a Human Fibrinogen Concentrate: Clinical Data from Adult and Pediatric Patients Requiring Fibrinogen for Bleeding Control and PreventionFrancois Stéphan, Loriane Gutermann, Stéphanie Bourget, et al.
Cardiology in the Young|March 17, 2016
Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE studyPascal Amedro, Adeline Basquin, Virginie Gressin, et al.
Joint Bone Spine|December 29, 2015
Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatmentThomas Bardin, Gérard Chalès, Tristan Pascart, et al.
Annals of the Rheumatic Diseases|November 27, 2012
Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management eraDavid Launay, Olivier Sitbon, Eric Hachulla, et al.
Arthritis Care & Research|August 4, 2015
Prevalence of Gout in the Adult Population of FranceThomas Bardin, Stéphane Bouée, Pierre Clerson, et al.
European Journal of Haematology|April 13, 2018
A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy-associated secondary immunodeficiencyOmar Benbrahim, Jean-François Viallard, Sylvain Choquet, et al.
Critical Care (London, England)|October 6, 2012
Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practiceThibaut Desmettre, Emilie Dehours, Charles-Marc Samama, et al.
Patient Preference and Adherence|July 27, 2017
A cohort of French pediatric patients with primary immunodeficiencies: are patient preferences regarding replacement immunotherapy fulfilled in real-life conditions?Marlène Pasquet, Isabelle Pellier, Nathalie Aladjidi, et al.
Chest|May 12, 2009
Is pulmonary arterial hypertension really a late complication of systemic sclerosis?Eric Hachulla, David Launay, Luc Mouthon, et al.
European Journal of Heart Failure|January 17, 2009
Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco ProgrammePascal de Groote, Richard Isnard, Pierre Clerson, et al.
Pageof 6